Shukra Pharmaceuticals Limited (BOM:524632)
India · Delayed Price · Currency is INR 31.93
-1.13 (-3.42%)
At close: Mar 27, 2026
Shukra Pharmaceuticals Market Cap
Shukra Pharmaceuticals has a market cap or net worth of 14.48 billion as of March 27, 2026. Its market cap has increased by 34.34% in one year.
Market Cap
14.48B
Enterprise Value
14.38B
Revenue
645.69M
Ranking
n/a
PE Ratio
83.37
Stock Price
31.93
Market Cap Chart
Since February 23, 2012, Shukra Pharmaceuticals's market cap has increased from 46.16M to 14.48B, an increase of 31,260.32%. That is a compound annual growth rate of 50.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 14.48B | -44.20% |
| Dec 31, 2025 | 25.94B | 334.48% |
| Dec 31, 2024 | 5.97B | 340.79% |
| Dec 29, 2023 | 1.35B | 554.74% |
| Dec 30, 2022 | 206.90M | 58.55% |
| Dec 30, 2021 | 130.50M | 105.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novartis India | 23.14B |
| Unichem Laboratories | 21.05B |
| Hikal | 20.41B |
| Morepen Laboratories | 20.26B |
| Kwality Pharmaceuticals | 15.11B |
| Amrutanjan Health Care | 14.94B |
| Lincoln Pharmaceuticals | 11.95B |
| Venus Remedies | 11.79B |